Archives

  • 2018-07
  • 2019-04
  • 2019-05
  • 2019-06
  • 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2019-12
  • 2020-01
  • 2020-02
  • 2020-03
  • 2020-04
  • 2020-05
  • 2020-06
  • 2020-07
  • 2020-08
  • 2020-09
  • 2020-10
  • 2020-11
  • 2020-12
  • 2021-01
  • 2021-02
  • 2021-03
  • 2021-04
  • 2021-05
  • 2021-06
  • 2021-07
  • 2021-08
  • 2021-09
  • 2021-10
  • 2021-11
  • 2021-12
  • 2022-01
  • 2022-02
  • 2022-03
  • 2022-04
  • 2022-05
  • 2022-06
  • 2022-07
  • 2022-08
  • 2022-09
  • 2022-10
  • 2022-11
  • 2022-12
  • 2023-01
  • 2023-02
  • 2023-03
  • 2023-04
  • 2023-05
  • 2023-06
  • 2023-07
  • 2023-08
  • 2023-09
  • 2023-10
  • 2023-11
  • 2023-12
  • 2024-01
  • 2024-02
  • 2024-03
  • 2024-04
  • Everolimus treatment showed an increase

    2020-11-25

    Everolimus treatment showed an increase in the number of plaques and a reduction in plaque size, depending on concentration and treatment time (Fig. 1, Fig. 2). Everolimus-pretreated pracinostat adsorbed less virus with more plaque formation in the initial phase of infection (Fig. 3). The ability and efficiency of infection by virus particles depends on the attachment to cellular receptors, uncoating, transport to the nucleus, and viral factors to establish infection. Infectivity per DNA copy number was 1.65 ± 1.22 PFU/1000 DNA copies in our four CMV stocks, and one infectious virus would be supported by many abortive viruses. Everolimus might modify the cells to be approximately 50% less susceptible to virus particles but support may be five times stronger for the cellular events required for establishing infection, resulting in an increase in plaque number but reduced and delayed DNA synthesis. Delayed and reduced viral DNA synthesis by everolimus may contribute to the reduced spread and small plaque formation in the everolimus-treated cultures. CMV replication is highly dependent on beneficial host cell translation functions. As a major regulator of cap-dependent translation initiation, the activation of mTOR is essential for CMV. Activated mTOR can phosphorylate 4E-BP, eIF4G, and S6K. Further, phosphorylation of 4E-BP and eIF4G can maintain the formation and integrity of the eIf4F complex, and thus maintain efficient translation (Clippinger et al., 2011a, b; Kudchodkar et al., 2007; Kudchodkar et al., 2004; Clippinger and Alwine, 2012). HCMV infection and the major HCMV immediate-early proteins (MIEPs) can active mTOR by activating P13K/Akt signalling, to maintain the eIF4F complex and translation (Kudchodkar et al., 2004). With respect to mTOR's role in translational control, HCMV depends on it early in infection but can bypass it later in infection (Clippinger and Alwine, 2012). It may be the reason why everolimus delayed HCMV DNA synthesis. It has been reported that HCMV induces mTOR-independent mechanisms for the phosphorylation of 4E-BP and eIF4G (Clippinger and Alwine, 2012; Clippinger et al., 2011a, b; Kudchodkar et al., 2004). It seems reasonable that everolimus, an mTOR inhibitor, can inhibit CMV, but many studies shown that everolimus inhibits CMV only to a modest extent. The reason is HCMV can circumvent the inhibition of mTOR and maintenance of mTORC1 activity by coocalization of mTOR and Ras homology enriched in brain protein-GTP in the perinuclear compartment by everolimus (Clippinger et al., 2011b). Thus it seems difficult to properly reconcile previous reports and the results of this study.
    Conclusion
    Conflicts of interest
    Acknowledgements
    Introduction Prophase I is the longest phase occupying about 85% of meiosis in Arabidopsis[1]. It can be further divided into five stages: leptotene, zygotene, pachytene, diplotene and diakinesis (Fig. 1). Before meiosis begins, pre-meiotic DNA replication produces pairs of sister chromatids, held together by cohesion complexes. Upon entry into leptotene, condensin complexes gradually compact chromatids to form thin threadlike structure discernable by light microscopy. During the leptotene-zygotene transition, initiation of meiotic recombination facilitates pairing of homologous chromosomes in a DNA sequence homology-dependent manner [2], which promotes the juxtaposed alignment of homologs at the zygotene stage. Subsequently, the synaptonemal complex (SC), a tripartite structure consisting of two parallel lateral elements and a central element, forms between homologs, and is thought to facilitate recombination by stabilizing homologous association. Synapsis begins during zygotene and culminates in pachytene when the fully synapsed homologs are visible as thick threadlike structures. Following the disassembly of SC after pachytene, two homologs are associated in a formation called a bivalent by sister chromatid cohesion and chiasmata. Importantly, chiasmata can be seen at this stage using light microscopy and is used to quantify the frequency and distribution of meiotic crossovers (COs). Subsequently, during diakinesis the bivalents become highly condensed in preparation for their arrangement on the metaphase plate (Fig. 1).